BrightPath Biotherapeutics Co., Ltd. Stock
Equities
4594
JP3274140007
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
59 JPY | 0.00% | +5.36% | -32.18% |
Sales 2017 | 529M 3.34M 4.56M | Sales 2018 | 354M 2.24M 3.05M | Capitalization | 33.68B 213M 290M |
---|---|---|---|---|---|
Net income 2017 | -1.11B -7.03M -9.6M | Net income 2018 | -1.58B -9.96M -13.6M | EV / Sales 2017 | 34.8 x |
Net cash position 2017 | 4.95B 31.26M 42.69M | Net cash position 2018 | 6.53B 41.23M 56.3M | EV / Sales 2018 | 76.7 x |
P/E ratio 2017 |
-19.2
x | P/E ratio 2018 |
-19.5
x | Employees | 42 |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 95.52% |
1 week | +5.36% | ||
Current month | -11.94% | ||
1 month | -7.81% | ||
3 months | -28.92% | ||
6 months | -47.79% | ||
Current year | -32.18% |
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Director/Board Member | 55 | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 15-05-31 | |
Akira Yamada
BRD | Director/Board Member | 67 | 03-04-30 |
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 59 | 0.00% | 69,000 |
24-04-25 | 59 | 0.00% | 87,800 |
24-04-24 | 59 | +1.72% | 249,500 |
24-04-23 | 58 | 0.00% | 248,700 |
24-04-22 | 58 | +3.57% | 273,700 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am
More quotes1st Jan change | Capi. | |
---|---|---|
-32.18% | 26.51M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- 4594 Stock